BRPI0721238A2 - Método de purificação da apolipoproteina a-1 - Google Patents
Método de purificação da apolipoproteina a-1Info
- Publication number
- BRPI0721238A2 BRPI0721238A2 BRPI0721238-0A BRPI0721238A BRPI0721238A2 BR PI0721238 A2 BRPI0721238 A2 BR PI0721238A2 BR PI0721238 A BRPI0721238 A BR PI0721238A BR PI0721238 A2 BRPI0721238 A2 BR PI0721238A2
- Authority
- BR
- Brazil
- Prior art keywords
- solution
- apoa
- apolipoprotein
- protein
- purification method
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 102000005666 Apolipoprotein A-I Human genes 0.000 title abstract 2
- 108010059886 Apolipoprotein A-I Proteins 0.000 title abstract 2
- 238000000746 purification Methods 0.000 title abstract 2
- 239000000243 solution Substances 0.000 abstract 5
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 3
- 239000004202 carbamide Substances 0.000 abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 125000000129 anionic group Chemical group 0.000 abstract 2
- 238000004587 chromatography analysis Methods 0.000 abstract 2
- 238000010828 elution Methods 0.000 abstract 2
- 239000012460 protein solution Substances 0.000 abstract 2
- 238000005194 fractionation Methods 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
Abstract
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200610147503A CN100586958C (zh) | 2006-12-20 | 2006-12-20 | 高纯度载脂蛋白a-i的制备方法 |
| CN200610147503.7 | 2006-12-20 | ||
| PCT/US2007/020258 WO2008088403A2 (en) | 2006-12-20 | 2007-09-19 | Method of purifying apolipoprotein a-1 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0721238A2 true BRPI0721238A2 (pt) | 2015-06-23 |
| BRPI0721238B1 BRPI0721238B1 (pt) | 2018-05-29 |
| BRPI0721238B8 BRPI0721238B8 (pt) | 2021-05-25 |
Family
ID=39565747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0721238A BRPI0721238B8 (pt) | 2006-12-20 | 2007-09-19 | método de purificação da apolipoproteina a-1 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP2125861B1 (pt) |
| JP (1) | JP2010513480A (pt) |
| KR (1) | KR101363106B1 (pt) |
| CN (1) | CN100586958C (pt) |
| AU (1) | AU2009202827B8 (pt) |
| BR (1) | BRPI0721238B8 (pt) |
| CA (1) | CA2673516C (pt) |
| EG (1) | EG26516A (pt) |
| MX (1) | MX2009006766A (pt) |
| MY (1) | MY154897A (pt) |
| RU (1) | RU2453555C2 (pt) |
| TW (1) | TWI357347B (pt) |
| WO (1) | WO2008088403A2 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120177610A1 (en) * | 2007-09-19 | 2012-07-12 | Kieu Hoang | Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins |
| CN102127165B (zh) * | 2010-01-15 | 2013-09-04 | 上海莱士血液制品股份有限公司 | 一种从血浆组分四沉淀中制备高纯ApoA-I的生产工艺 |
| HUE032560T2 (en) * | 2010-06-30 | 2017-09-28 | Csl Ltd | Dissolved high density lipoprotein formulation and preparation process |
| CN102731642B (zh) * | 2011-04-14 | 2014-01-29 | 上海莱士血液制品股份有限公司 | 从人血浆组分四沉淀制备高纯Apoa-I的生产工艺 |
| JP5924624B2 (ja) * | 2011-04-28 | 2016-05-25 | 国立研究開発法人理化学研究所 | 生物材料を透明化する方法、及びその利用 |
| JP6044900B2 (ja) | 2011-05-20 | 2016-12-14 | 国立研究開発法人理化学研究所 | 生物材料用透明化試薬、及びその利用 |
| US20130053551A1 (en) | 2011-08-25 | 2013-02-28 | Hoffman-La Roche. Inc. | Cation and anion exchange chromatography method |
| CN103505720A (zh) * | 2012-06-30 | 2014-01-15 | 复旦大学 | 载脂蛋白a-i在制备预防和治疗肝病代谢综合征药物中的用途 |
| US9534029B2 (en) | 2012-10-03 | 2017-01-03 | Csl Behring Ag | Method of purifying proteins |
| WO2015022883A1 (ja) | 2013-08-14 | 2015-02-19 | 独立行政法人理化学研究所 | 光透過性に優れた生物材料を調製するための組成物およびその利用 |
| CN107033237B (zh) * | 2017-05-11 | 2021-07-20 | 深圳市卫光生物制品股份有限公司 | 一种人血浆载脂蛋白a-i的分离纯化方法 |
| CN110590935B (zh) * | 2019-09-23 | 2024-01-30 | 华兰生物工程重庆有限公司 | 人血白蛋白去除多聚体工艺 |
| CN111153985B (zh) * | 2020-01-20 | 2023-06-13 | 宁波赛珀生物技术有限公司 | 血清载脂蛋白a-ii的分离纯化方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1752187A3 (ru) * | 1990-12-11 | 1992-07-30 | А.Б.Сигалов | Способ делипидировани лиофилизированных липопротеинов высокой плотности из сыворотки крови человека |
| WO1993000443A1 (en) * | 1991-06-26 | 1993-01-07 | Bio-Technology General Corp. | Purification of recombinant apolipoprotein e from bacteria |
| SE9500778D0 (sv) * | 1995-03-03 | 1995-03-03 | Pharmacia Ab | Process for producing a protein |
| SE9603068D0 (sv) * | 1996-08-23 | 1996-08-23 | Pharmacia & Upjohn Ab | Process for purifying a protein |
| HK1082661A1 (zh) * | 2002-07-30 | 2006-06-16 | Esperion Therapeutics Inc. | 使用非人类动物载脂蛋白a-i蛋白的方法 |
-
2006
- 2006-12-20 CN CN200610147503A patent/CN100586958C/zh active Active
-
2007
- 2007-09-19 MX MX2009006766A patent/MX2009006766A/es active IP Right Grant
- 2007-09-19 BR BRPI0721238A patent/BRPI0721238B8/pt not_active IP Right Cessation
- 2007-09-19 MY MYPI20092514A patent/MY154897A/en unknown
- 2007-09-19 KR KR1020097014720A patent/KR101363106B1/ko not_active Expired - Fee Related
- 2007-09-19 JP JP2009542756A patent/JP2010513480A/ja active Pending
- 2007-09-19 CA CA2673516A patent/CA2673516C/en active Active
- 2007-09-19 RU RU2009127816/04A patent/RU2453555C2/ru active
- 2007-09-19 WO PCT/US2007/020258 patent/WO2008088403A2/en not_active Ceased
- 2007-09-19 EP EP07861342.9A patent/EP2125861B1/en not_active Not-in-force
- 2007-11-30 TW TW096145616A patent/TWI357347B/zh not_active IP Right Cessation
-
2009
- 2009-06-18 EG EG2009060940A patent/EG26516A/en active
- 2009-07-14 AU AU2009202827A patent/AU2009202827B8/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008088403A2 (en) | 2008-07-24 |
| JP2010513480A (ja) | 2010-04-30 |
| CN100586958C (zh) | 2010-02-03 |
| AU2009202827A8 (en) | 2012-03-08 |
| CA2673516C (en) | 2013-10-08 |
| BRPI0721238B1 (pt) | 2018-05-29 |
| TW200922675A (en) | 2009-06-01 |
| EP2125861A4 (en) | 2011-02-02 |
| AU2009202827B8 (en) | 2012-03-08 |
| AU2009202827B2 (en) | 2011-12-15 |
| RU2453555C2 (ru) | 2012-06-20 |
| AU2009202827A1 (en) | 2009-08-06 |
| EP2125861A2 (en) | 2009-12-02 |
| KR20090116706A (ko) | 2009-11-11 |
| MY154897A (en) | 2015-08-28 |
| KR101363106B1 (ko) | 2014-02-13 |
| CN101205250A (zh) | 2008-06-25 |
| WO2008088403A3 (en) | 2008-11-06 |
| MX2009006766A (es) | 2009-08-12 |
| CA2673516A1 (en) | 2008-07-24 |
| EP2125861B1 (en) | 2014-07-16 |
| TWI357347B (en) | 2012-02-01 |
| BRPI0721238B8 (pt) | 2021-05-25 |
| RU2009127816A (ru) | 2011-01-27 |
| EG26516A (en) | 2014-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0721238A2 (pt) | Método de purificação da apolipoproteina a-1 | |
| AR133787A2 (es) | Métodos y composiciones que comprenden polipéptidos recombinantes purificados | |
| ECSP099403A (es) | Formulacion parenteral del anticuerpo abeta | |
| BR112012009289A8 (pt) | Método para purificar um anticorpo anti-il-13 a partir de uma mistura de amostra que compreende um anticorpo anti-il-13 e pelo menos uma proteína de célula hospedeira (hcp) | |
| AR063829A1 (es) | Moleculas de enlace de lingo y uso farmaceutico de las mismas | |
| AR072897A1 (es) | Composiciones y metodos para anticuerpos que se dirigen a la proteina de complemento c5 | |
| BRPI0610197B8 (pt) | anticorpo de ligação à esclerostina, processo para a produção do mesmo, composição farmacêutica que compreende o dito anticorpo e vetor de clonagem ou expressão | |
| AR074015A1 (es) | Purificacion de proteinas acidas utilizando cromatografia de hidroxiapatita ceramica | |
| BR112012024956A2 (pt) | processo para a purificação de uma proteína de fator de crescimento | |
| BR112014012275A2 (pt) | purificação de proteína com a utilização de tampão bis-tris | |
| BR112012022223A2 (pt) | formulações de proteína concentrada e usos das mesmas | |
| CL2011003122A1 (es) | Anticuerpo que se une a la proteina tau fosforilada en la serina 422 (tau ps422), pero no se une a la tau ni al fragmento mcak fosforilado; acido nucleico que lo codifica; metodo de produccion; composicion farmaceutica; y uso util en el tratamiento de una tauopatia, tal como la enfermedad de alzheimer. | |
| NZ598395A (en) | Methods for purification of alpha-1-antitrypsin and apolipoprotein A-I | |
| BRPI0911035B8 (pt) | ativadores de pirrolidinona glicoquinase | |
| BRPI0715408B8 (pt) | Processo para a preparação de 5-(1-alquiltio)alquilpiridinas 2-substituída | |
| BR112013019508A2 (pt) | purificação de insulina | |
| BR112012009227A2 (pt) | métodos e sistemas para purificar neurotoxina botulínica não complexada | |
| BRPI0517973A (pt) | método para purificar o fsh | |
| PE20150720A1 (es) | Purificacion de iduronato-2-sulfatasa | |
| EA201491564A1 (ru) | Осаждение фракции i-iv-1 иммуноглобулинов из плазмы | |
| EA201001288A1 (ru) | Лечение гипертонии 25-гидроксивитамином d3 | |
| BRPI0701684A (pt) | composição cosmética ou farmacêutica, processo de tratamento cosmético, uso de um composto e composto | |
| ATE443722T1 (de) | Peptide und peptidderivate, ihre herstellung sowie ihre verwendung zur herstellung einer therapeutisch und/oder prophylaktisch wirksamen pharmazeutischen zusammensetzung | |
| CL2008003675A1 (es) | Compuestos derivados de 5-alquil o alquenil 3-cianopiridinas, procedimiento de preparacion, composicion farmaceutica, util para reducir la actividad incrementada de una enzima en un mamifero, en donde dicha enzima es una proteina quinasa, destinado al tratamiento de la inflamacion, asma, colitis, esclerosis multiple, soriasis, artritis reumatoide. | |
| BRPI0507111A (pt) | processo para a preparação de um composto e seus adutos de mannich, composição, concentrado aditivo para combustìveis, e, usos de uma composição e de pelo menos um composto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B15G | Petition not considered as such [chapter 15.7 patent gazette] |
Free format text: NAO CONHECIDA A PETICAO 016100007277 DE 21/12/2010, EM VIRTUDE DO DISPOSTO ARTIGO 219, INCISO II LPI. |
|
| B151 | Others concerning applications: resolution cancelled [chapter 15.31 patent gazette] |
Free format text: REFERENTE AO DESPACHO 15.7 PUBLICADO NA RPI 2130 DE 01/11/2011. |
|
| B15G | Petition not considered as such [chapter 15.7 patent gazette] |
Free format text: DA PETICAO NO 16100007277 DE 21/12/2010, NAO CONHECIDA A GUIA 221010949343 DE 20/12/2010, REFERENTE A TAXA DE RESTAURACAO EM VIRTUDE DO DISPOSTO ARTIGO 219, INCISO II DA LPI. |
|
| B65X | Notification of requirement for priority examination of patent application | ||
| B65Z | Priority examination of the patent application refused (request does not comply with dec. 132/06 of 20061117) |
Free format text: NEGADO O EXAME PRIORITARIO DO PEDIDO DE PATENTE UMA VEZ QUE NAO FOI ATENDIDO O DISPOSTO NO ART. 6O, I DA RESOLUCAO 068/13. |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/05/2018, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/09/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 17A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2793 DE 16-07-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |